Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCT
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Donna Gregory, RNC, BSN
Ohio State University
Study Director - Kartik Venkatesh, MD, PhD
Ohio State University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Tuscaloosa, Alabama, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- the Ohio State University Wexner Medical Center Ob/gyn Maternal and Fetal Medicine
Columbus, Ohio, United States
- Premier Health - Miami Valley Hospital
Dayton, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2025
- Primary completion
- 31 Dec 2029
- Completion
- 31 Dec 2030
- Last update posted
- 28 Oct 2025
- Registered enrollment
- 0
- Registry id
- NCT06490874
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.